Posted August 6, 2017

 

CANTON, Mass. – Draper Therapies announced that the United States Food and Drug Administration (FDA) has determined that products containing Celliant® meet the criteria for medical devices and general wellness products and will be categorized as such.

 

According to the company, all of Draper Therapies’ products contain Celliant, a smart fiber clinically proven to:

 

• Increase Energy – this energy penetrates into the muscle and tissue to promote a temporary increase in local blood flow;

• Better/more endurance;

• Faster/quicker recovery;

• Enhance/increase performance;

• Increase/enhance/more speed;

• Improve/increase strength;

• Increase/more stamina;

• Recycled human energy; and

• Promote restful sleep

• Help increase comfort and promotes restful sleep

 

After 11 years of producing and working with Celliant fabrics, Kristin Draper, president of Draper Therapies said sshe isn’t surprised.

 

“When I was first introduced to Celliant® I was a skeptic too,” said Draper, the sixth generation of the Draper family to run the business, part of Draper Knitting, “but after seeing the remarkable way it reduced inflammation on myself and my family, we knew this was a winner. We have been working with Seth (of Hologenix LLC, the company responsible for inventing Celliant) since the beginning and made fabrics, then equestrian products, which lead to dog and human products. It continues to amaze me – the very human testimonials about how products made with Celliant are making lives better.”

 

Celliant products will be regulated as both medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act, and are also as “general wellness products.”

 

The FDA has defined a general wellness product as one that has (1) an intended use that relates to maintaining or encouraging a general state of health or a healthy activity, or (2) an intended use that relates the role of a healthy lifestyle with helping to reduce the risk or impact of certain chronic diseases or conditions and where it is well understood and accepted that healthy lifestyle choices may play an important role in health outcomes for the disease or condition.

 

“Our customers and anyone who has used Celliant knows that it works, but this just lends credence to our experience,” said Becky Shipps, Draper’s Therapies product manager. “I think that FDA approval is incredibly important because it will encourage folks to try our products and generate interest in responsive textiles in general. I am excited for the future of both Draper Therapies and Celliant.”

 

Source: Draper Therapies